+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
Ethical Pharmaceuticals Market Report 2026 - Product Thumbnail Image

Ethical Pharmaceuticals Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Rnai Drug Delivery Market 2024-2028 - Product Thumbnail Image

Rnai Drug Delivery Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
From
Halal Insulin Market - Global Forecast 2025-2030 - Product Thumbnail Image

Halal Insulin Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Recombinant Growth Hormone Market - Global Forecast 2025-2030 - Product Thumbnail Image

Recombinant Growth Hormone Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Mealtime Insulin Market - Global Forecast 2025-2030 - Product Thumbnail Image

Mealtime Insulin Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
From
Insulin Drugs Market Report 2026 - Product Thumbnail Image

Insulin Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Insulin Analog Market - Global Forecast to 2030 - Product Thumbnail Image

Insulin Analog Market - Global Forecast to 2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Loading Indicator